Report Detail

Request for Sample of this report

Other Global Newborn Disease Screening Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4625150
    • |
  • 12 March, 2026
    • |
  • Global
    • |
  • 106 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global Newborn Disease Screening market size was valued at US$ 1116 million in 2025 and is forecast to a readjusted size of US$ 1664 million by 2032 with a CAGR of 5.9% during review period.
Newborn Disease Screening is the organized process of testing infants shortly after birth to identify serious conditions that are not obvious at the time of delivery but can cause severe harm if not treated early. It encompasses sample collection, laboratory screening for selected disorders, communication of results to caregivers and clinicians, confirmatory testing for abnormal findings, and referral into timely treatment and long term follow up care pathways.
The newborn disease screening market is best viewed as a mission critical component of maternal and child health systems with demand anchored by universal clinical need and public health mandates rather than discretionary utilization. Market evolution is driven primarily by program scope expansion, improvements in analytical performance, and modernization of operational workflows such as automation, digital reporting, and coordinated follow up. Competitive dynamics tend to favor incumbent laboratories and technology suppliers that can demonstrate long term reliability, regulatory compliance, and interoperability with hospital and public health information systems, creating high barriers for new entrants and limiting price led disruption. As the field advances, the key strategic tension is balancing broader disease coverage with evidence of clinical utility and system capacity for confirmatory testing and treatment, making governance alignment and downstream care readiness as important as the screening technology itself.
This report is a detailed and comprehensive analysis for global Newborn Disease Screening market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Newborn Disease Screening market size and forecasts, in consumption value ($ Million), 2021-2032
Global Newborn Disease Screening market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Newborn Disease Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Newborn Disease Screening market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Newborn Disease Screening
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Newborn Disease Screening market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Revvity, Quest Diagnostics, MedGenome, Mayo Clinic Laboratories, GeneDx, PreventionGenetics, SYNLAB, Cordlife, BGI Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Newborn Disease Screening market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Genetic Sequencing
Hearing Screening
Pulse Oximetry
Others
Market segment by Screening Purpose
Core Condition Screening
Expanded Condition Screening
Market segment by Service Model
Public Health Program
Consumer
Others
Market segment by Application
Public Hospitals
Private Hospitals
Others
Market segment by players, this report covers
Thermo Fisher Scientific
Revvity
Quest Diagnostics
MedGenome
Mayo Clinic Laboratories
GeneDx
PreventionGenetics
SYNLAB
Cordlife
BGI Genomics
Berry Genomics
Annaroad
Jiajian Medical Testing
Genesky
Weihansi Biomedical Technology
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Newborn Disease Screening product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Newborn Disease Screening, with revenue, gross margin, and global market share of Newborn Disease Screening from 2021 to 2026.
Chapter 3, the Newborn Disease Screening competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Newborn Disease Screening market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Newborn Disease Screening.
Chapter 13, to describe Newborn Disease Screening research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Newborn Disease Screening by Type
    • 1.3.1 Overview: Global Newborn Disease Screening Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Newborn Disease Screening Consumption Value Market Share by Type in 2025
    • 1.3.3 Genetic Sequencing
    • 1.3.4 Hearing Screening
    • 1.3.5 Pulse Oximetry
    • 1.3.6 Others
  • 1.4 Classification of Newborn Disease Screening by Screening Purpose
    • 1.4.1 Overview: Global Newborn Disease Screening Market Size by Screening Purpose: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Newborn Disease Screening Consumption Value Market Share by Screening Purpose in 2025
    • 1.4.3 Core Condition Screening
    • 1.4.4 Expanded Condition Screening
  • 1.5 Classification of Newborn Disease Screening by Service Model
    • 1.5.1 Overview: Global Newborn Disease Screening Market Size by Service Model: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Newborn Disease Screening Consumption Value Market Share by Service Model in 2025
    • 1.5.3 Public Health Program
    • 1.5.4 Consumer
    • 1.5.5 Others
  • 1.6 Global Newborn Disease Screening Market by Application
    • 1.6.1 Overview: Global Newborn Disease Screening Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Public Hospitals
    • 1.6.3 Private Hospitals
    • 1.6.4 Others
  • 1.7 Global Newborn Disease Screening Market Size & Forecast
  • 1.8 Global Newborn Disease Screening Market Size and Forecast by Region
    • 1.8.1 Global Newborn Disease Screening Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Newborn Disease Screening Market Size by Region, (2021-2032)
    • 1.8.3 North America Newborn Disease Screening Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Newborn Disease Screening Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Newborn Disease Screening Market Size and Prospect (2021-2032)
    • 1.8.6 South America Newborn Disease Screening Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Newborn Disease Screening Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Newborn Disease Screening Product and Solutions
    • 2.1.4 Thermo Fisher Scientific Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.2 Revvity
    • 2.2.1 Revvity Details
    • 2.2.2 Revvity Major Business
    • 2.2.3 Revvity Newborn Disease Screening Product and Solutions
    • 2.2.4 Revvity Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Revvity Recent Developments and Future Plans
  • 2.3 Quest Diagnostics
    • 2.3.1 Quest Diagnostics Details
    • 2.3.2 Quest Diagnostics Major Business
    • 2.3.3 Quest Diagnostics Newborn Disease Screening Product and Solutions
    • 2.3.4 Quest Diagnostics Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Quest Diagnostics Recent Developments and Future Plans
  • 2.4 MedGenome
    • 2.4.1 MedGenome Details
    • 2.4.2 MedGenome Major Business
    • 2.4.3 MedGenome Newborn Disease Screening Product and Solutions
    • 2.4.4 MedGenome Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 MedGenome Recent Developments and Future Plans
  • 2.5 Mayo Clinic Laboratories
    • 2.5.1 Mayo Clinic Laboratories Details
    • 2.5.2 Mayo Clinic Laboratories Major Business
    • 2.5.3 Mayo Clinic Laboratories Newborn Disease Screening Product and Solutions
    • 2.5.4 Mayo Clinic Laboratories Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Mayo Clinic Laboratories Recent Developments and Future Plans
  • 2.6 GeneDx
    • 2.6.1 GeneDx Details
    • 2.6.2 GeneDx Major Business
    • 2.6.3 GeneDx Newborn Disease Screening Product and Solutions
    • 2.6.4 GeneDx Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 GeneDx Recent Developments and Future Plans
  • 2.7 PreventionGenetics
    • 2.7.1 PreventionGenetics Details
    • 2.7.2 PreventionGenetics Major Business
    • 2.7.3 PreventionGenetics Newborn Disease Screening Product and Solutions
    • 2.7.4 PreventionGenetics Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 PreventionGenetics Recent Developments and Future Plans
  • 2.8 SYNLAB
    • 2.8.1 SYNLAB Details
    • 2.8.2 SYNLAB Major Business
    • 2.8.3 SYNLAB Newborn Disease Screening Product and Solutions
    • 2.8.4 SYNLAB Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 SYNLAB Recent Developments and Future Plans
  • 2.9 Cordlife
    • 2.9.1 Cordlife Details
    • 2.9.2 Cordlife Major Business
    • 2.9.3 Cordlife Newborn Disease Screening Product and Solutions
    • 2.9.4 Cordlife Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Cordlife Recent Developments and Future Plans
  • 2.10 BGI Genomics
    • 2.10.1 BGI Genomics Details
    • 2.10.2 BGI Genomics Major Business
    • 2.10.3 BGI Genomics Newborn Disease Screening Product and Solutions
    • 2.10.4 BGI Genomics Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 BGI Genomics Recent Developments and Future Plans
  • 2.11 Berry Genomics
    • 2.11.1 Berry Genomics Details
    • 2.11.2 Berry Genomics Major Business
    • 2.11.3 Berry Genomics Newborn Disease Screening Product and Solutions
    • 2.11.4 Berry Genomics Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Berry Genomics Recent Developments and Future Plans
  • 2.12 Annaroad
    • 2.12.1 Annaroad Details
    • 2.12.2 Annaroad Major Business
    • 2.12.3 Annaroad Newborn Disease Screening Product and Solutions
    • 2.12.4 Annaroad Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Annaroad Recent Developments and Future Plans
  • 2.13 Jiajian Medical Testing
    • 2.13.1 Jiajian Medical Testing Details
    • 2.13.2 Jiajian Medical Testing Major Business
    • 2.13.3 Jiajian Medical Testing Newborn Disease Screening Product and Solutions
    • 2.13.4 Jiajian Medical Testing Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Jiajian Medical Testing Recent Developments and Future Plans
  • 2.14 Genesky
    • 2.14.1 Genesky Details
    • 2.14.2 Genesky Major Business
    • 2.14.3 Genesky Newborn Disease Screening Product and Solutions
    • 2.14.4 Genesky Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Genesky Recent Developments and Future Plans
  • 2.15 Weihansi Biomedical Technology
    • 2.15.1 Weihansi Biomedical Technology Details
    • 2.15.2 Weihansi Biomedical Technology Major Business
    • 2.15.3 Weihansi Biomedical Technology Newborn Disease Screening Product and Solutions
    • 2.15.4 Weihansi Biomedical Technology Newborn Disease Screening Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Weihansi Biomedical Technology Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Newborn Disease Screening Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Newborn Disease Screening by Company Revenue
    • 3.2.2 Top 3 Newborn Disease Screening Players Market Share in 2025
    • 3.2.3 Top 6 Newborn Disease Screening Players Market Share in 2025
  • 3.3 Newborn Disease Screening Market: Overall Company Footprint Analysis
    • 3.3.1 Newborn Disease Screening Market: Region Footprint
    • 3.3.2 Newborn Disease Screening Market: Company Product Type Footprint
    • 3.3.3 Newborn Disease Screening Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Newborn Disease Screening Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Newborn Disease Screening Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Newborn Disease Screening Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Newborn Disease Screening Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Newborn Disease Screening Consumption Value by Type (2021-2032)
  • 6.2 North America Newborn Disease Screening Market Size by Application (2021-2032)
  • 6.3 North America Newborn Disease Screening Market Size by Country
    • 6.3.1 North America Newborn Disease Screening Consumption Value by Country (2021-2032)
    • 6.3.2 United States Newborn Disease Screening Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Newborn Disease Screening Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Newborn Disease Screening Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Newborn Disease Screening Consumption Value by Type (2021-2032)
  • 7.2 Europe Newborn Disease Screening Consumption Value by Application (2021-2032)
  • 7.3 Europe Newborn Disease Screening Market Size by Country
    • 7.3.1 Europe Newborn Disease Screening Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Newborn Disease Screening Market Size and Forecast (2021-2032)
    • 7.3.3 France Newborn Disease Screening Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Newborn Disease Screening Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Newborn Disease Screening Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Newborn Disease Screening Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Newborn Disease Screening Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Newborn Disease Screening Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Newborn Disease Screening Market Size by Region
    • 8.3.1 Asia-Pacific Newborn Disease Screening Consumption Value by Region (2021-2032)
    • 8.3.2 China Newborn Disease Screening Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Newborn Disease Screening Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Newborn Disease Screening Market Size and Forecast (2021-2032)
    • 8.3.5 India Newborn Disease Screening Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Newborn Disease Screening Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Newborn Disease Screening Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Newborn Disease Screening Consumption Value by Type (2021-2032)
  • 9.2 South America Newborn Disease Screening Consumption Value by Application (2021-2032)
  • 9.3 South America Newborn Disease Screening Market Size by Country
    • 9.3.1 South America Newborn Disease Screening Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Newborn Disease Screening Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Newborn Disease Screening Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Newborn Disease Screening Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Newborn Disease Screening Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Newborn Disease Screening Market Size by Country
    • 10.3.1 Middle East & Africa Newborn Disease Screening Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Newborn Disease Screening Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Newborn Disease Screening Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Newborn Disease Screening Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Newborn Disease Screening Market Drivers
  • 11.2 Newborn Disease Screening Market Restraints
  • 11.3 Newborn Disease Screening Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Newborn Disease Screening Industry Chain
  • 12.2 Newborn Disease Screening Upstream Analysis
  • 12.3 Newborn Disease Screening Midstream Analysis
  • 12.4 Newborn Disease Screening Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Newborn Disease Screening. Industry analysis & Market Report on Newborn Disease Screening is a syndicated market report, published as Global Newborn Disease Screening Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Newborn Disease Screening market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo